ID   ZSC29_HUMAN             Reviewed;         852 AA.
AC   Q8IWY8; B3KVB9; Q32M75; Q32M76; Q8NA40;
DT   02-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   22-SEP-2009, sequence version 2.
DT   28-JUN-2023, entry version 160.
DE   RecName: Full=Zinc finger and SCAN domain-containing protein 29;
DE   AltName: Full=Zinc finger protein 690;
GN   Name=ZSCAN29; Synonyms=ZNF690;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANTS
RP   GLY-104 AND SER-199.
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 2-852 (ISOFORM 1).
RC   TISSUE=Erythroid cell;
RX   PubMed=12434312; DOI=10.1086/344781;
RA   Dgany O., Avidan N., Delaunay J., Krasnov T., Shalmon L., Shalev H.,
RA   Eidelitz-Markus T., Kapelushnik J., Cattan D., Pariente A., Tulliez M.,
RA   Cretien A., Schischmanoff P.-O., Iolascon A., Fibach E., Koren A.,
RA   Roessler J., Le Merrer M., Yaniv I., Zaizov R., Ben-Asher E., Olender T.,
RA   Lancet D., Beckmann J.S., Tamary H.;
RT   "Congenital dyserythropoietic anemia type I is caused by mutations in
RT   codanin-1.";
RL   Am. J. Hum. Genet. 71:1467-1474(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2-852 (ISOFORMS 3 AND 4).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-153 AND SER-561, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-153, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [7]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-112; LYS-180; LYS-576 AND
RP   LYS-652, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: May be involved in transcriptional regulation.
CC   -!- INTERACTION:
CC       Q8IWY8-3; Q9BRL7: SEC22C; NbExp=3; IntAct=EBI-14188237, EBI-10297029;
CC       Q8IWY8-3; Q9NWS9-2: ZNF446; NbExp=3; IntAct=EBI-14188237, EBI-740232;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q8IWY8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8IWY8-2; Sequence=VSP_018179;
CC       Name=3;
CC         IsoId=Q8IWY8-3; Sequence=VSP_018181, VSP_018182;
CC       Name=4;
CC         IsoId=Q8IWY8-4; Sequence=VSP_018180;
CC   -!- SIMILARITY: Belongs to the krueppel C2H2-type zinc-finger protein
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK093186; BAC04088.1; -; mRNA.
DR   EMBL; AK122788; BAG53731.1; -; mRNA.
DR   EMBL; AF525399; AAO14995.1; -; mRNA.
DR   EMBL; BC109270; AAI09271.1; -; mRNA.
DR   EMBL; BC109271; AAI09272.1; -; mRNA.
DR   CCDS; CCDS10095.2; -. [Q8IWY8-1]
DR   RefSeq; NP_689668.3; NM_152455.3. [Q8IWY8-1]
DR   RefSeq; XP_006720464.1; XM_006720401.3.
DR   RefSeq; XP_011519568.1; XM_011521266.2.
DR   AlphaFoldDB; Q8IWY8; -.
DR   SMR; Q8IWY8; -.
DR   BioGRID; 126960; 28.
DR   IntAct; Q8IWY8; 12.
DR   STRING; 9606.ENSP00000380174; -.
DR   iPTMnet; Q8IWY8; -.
DR   PhosphoSitePlus; Q8IWY8; -.
DR   BioMuta; ZSCAN29; -.
DR   DMDM; 259016454; -.
DR   EPD; Q8IWY8; -.
DR   jPOST; Q8IWY8; -.
DR   MassIVE; Q8IWY8; -.
DR   MaxQB; Q8IWY8; -.
DR   PaxDb; Q8IWY8; -.
DR   PeptideAtlas; Q8IWY8; -.
DR   ProteomicsDB; 70928; -. [Q8IWY8-1]
DR   ProteomicsDB; 70929; -. [Q8IWY8-2]
DR   ProteomicsDB; 70930; -. [Q8IWY8-3]
DR   ProteomicsDB; 70931; -. [Q8IWY8-4]
DR   ABCD; Q8IWY8; 10 sequenced antibodies.
DR   Antibodypedia; 11192; 140 antibodies from 22 providers.
DR   DNASU; 146050; -.
DR   Ensembl; ENST00000396976.6; ENSP00000380174.2; ENSG00000140265.14. [Q8IWY8-1]
DR   Ensembl; ENST00000684362.1; ENSP00000507363.1; ENSG00000140265.14. [Q8IWY8-1]
DR   GeneID; 146050; -.
DR   KEGG; hsa:146050; -.
DR   MANE-Select; ENST00000684362.1; ENSP00000507363.1; NM_001372080.1; NP_001359009.1.
DR   UCSC; uc001zrk.2; human. [Q8IWY8-1]
DR   AGR; HGNC:26673; -.
DR   CTD; 146050; -.
DR   GeneCards; ZSCAN29; -.
DR   HGNC; HGNC:26673; ZSCAN29.
DR   HPA; ENSG00000140265; Low tissue specificity.
DR   neXtProt; NX_Q8IWY8; -.
DR   OpenTargets; ENSG00000140265; -.
DR   PharmGKB; PA162411015; -.
DR   VEuPathDB; HostDB:ENSG00000140265; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   GeneTree; ENSGT00940000161523; -.
DR   HOGENOM; CLU_002678_88_0_1; -.
DR   InParanoid; Q8IWY8; -.
DR   OMA; ERGEPWV; -.
DR   OrthoDB; 420077at2759; -.
DR   PhylomeDB; Q8IWY8; -.
DR   TreeFam; TF336839; -.
DR   PathwayCommons; Q8IWY8; -.
DR   SignaLink; Q8IWY8; -.
DR   BioGRID-ORCS; 146050; 14 hits in 1177 CRISPR screens.
DR   ChiTaRS; ZSCAN29; human.
DR   GenomeRNAi; 146050; -.
DR   Pharos; Q8IWY8; Tdark.
DR   PRO; PR:Q8IWY8; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   RNAct; Q8IWY8; protein.
DR   Bgee; ENSG00000140265; Expressed in secondary oocyte and 196 other tissues.
DR   ExpressionAtlas; Q8IWY8; baseline and differential.
DR   Genevisible; Q8IWY8; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; IDA:ARUK-UCL.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   CDD; cd07936; SCAN; 1.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 6.
DR   Gene3D; 1.10.4020.10; DNA breaking-rejoining enzymes; 1.
DR   Gene3D; 1.10.10.60; Homeodomain-like; 2.
DR   InterPro; IPR044822; Myb_DNA-bind_4.
DR   InterPro; IPR003309; SCAN_dom.
DR   InterPro; IPR038269; SCAN_sf.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   PANTHER; PTHR23226; ZINC FINGER AND SCAN DOMAIN-CONTAINING; 1.
DR   PANTHER; PTHR23226:SF184; ZINC FINGER AND SCAN DOMAIN-CONTAINING PROTEIN 29; 1.
DR   Pfam; PF13837; Myb_DNA-bind_4; 2.
DR   Pfam; PF02023; SCAN; 1.
DR   Pfam; PF00096; zf-C2H2; 6.
DR   SMART; SM00431; SCAN; 1.
DR   SMART; SM00355; ZnF_C2H2; 6.
DR   SUPFAM; SSF57667; beta-beta-alpha zinc fingers; 4.
DR   SUPFAM; SSF47353; Retrovirus capsid dimerization domain-like; 1.
DR   PROSITE; PS50804; SCAN_BOX; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 6.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 6.
PE   1: Evidence at protein level;
KW   Alternative splicing; DNA-binding; Isopeptide bond; Metal-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; Transcription;
KW   Transcription regulation; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..852
FT                   /note="Zinc finger and SCAN domain-containing protein 29"
FT                   /id="PRO_0000234011"
FT   DOMAIN          18..100
FT                   /note="SCAN box"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00187"
FT   ZN_FING         678..700
FT                   /note="C2H2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         706..728
FT                   /note="C2H2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         734..756
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         762..784
FT                   /note="C2H2-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         790..812
FT                   /note="C2H2-type 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         818..840
FT                   /note="C2H2-type 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   REGION          96..182
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          347..400
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          502..557
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          603..625
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        141..155
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        362..376
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        508..522
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        528..546
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         153
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         561
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   CROSSLNK        112
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        180
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        576
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        652
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         1..120
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_018179"
FT   VAR_SEQ         176..564
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_018180"
FT   VAR_SEQ         495..557
FT                   /note="SVRVAAPPNDGQEETASCPVQGTSEAEAQKQAEEADEATEEDSDDDEEDTEI
FT                   PPGAVITRAPV -> LKLDLRMKIIQNGIFLRKYNCIGHYLQDLKGKFPGIFIRVKAMR
FT                   VTVDQEDSGQRPQGRKEEN (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_018181"
FT   VAR_SEQ         558..852
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_018182"
FT   VARIANT         104
FT                   /note="R -> G (in dbSNP:rs3809482)"
FT                   /evidence="ECO:0000269|PubMed:14702039"
FT                   /id="VAR_059949"
FT   VARIANT         199
FT                   /note="G -> S (in dbSNP:rs3917221)"
FT                   /evidence="ECO:0000269|PubMed:14702039"
FT                   /id="VAR_057459"
FT   CONFLICT        182
FT                   /note="G -> S (in Ref. 3; AAI09271)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   852 AA;  96719 MW;  B92BE704821F8EC8 CRC64;
     MMAKSALREN GTNSETFRQR FRRFHYQEVA GPREAFSQLW ELCCRWLRPE VRTKEQIVEL
     LVLEQFLTVL PGEIQNWVQE QCPENGEEAV TLVEDLEREP GRPRSSVTVS VKGQEVRLEK
     MTPPKSSQEL LSVRQESVEP QPRGVPKKER ARSPDLGPQE QMNPKEKLKP FQRSGLPFPK
     SGVVSRLEQG EPWIPDLLGS KEKELPSGSH IGDRRVHADL LPSKKDRRSW VEQDHWSFED
     EKVAGVHWGY EETRTLLAIL SQTEFYEALR NCHRNSQVYG AVAERLREYG FLRTLEQCRT
     KFKGLQKSYR KVKSGHPPET CPFFEEMEAL MSAQVIALPS NGLEAAASHS GLVGSDAETE
     EPGQRGWQHE EGAEEAVAQE SDSDDMDLEA TPQDPNSAAP VVFRSPGGVH WGYEETKTYL
     AILSETQFYE ALRNCHRNSQ LYGAVAERLW EYGFLRTPEQ CRTKFKSLQT SYRKVKNGQA
     PETCPFFEEM DALVSVRVAA PPNDGQEETA SCPVQGTSEA EAQKQAEEAD EATEEDSDDD
     EEDTEIPPGA VITRAPVLFQ SPRGFEAGFE NEDNSKRDIS EEVQLHRTLL ARSERKIPRY
     LHQGKGNESD CRSGRQWAKT SGEKRGKLTL PEKSLSEVLS QQRPCLGERP YKYLKYSKSF
     GPNSLLMHQV SHQVENPYKC ADCGKSFSRS ARLIRHRRIH TGEKPYKCLD CGKSFRDSSN
     FITHRRIHTG EKPYQCGECG KCFNQSSSLI IHQRTHTGEK PYQCEECGKS FNNSSHFSAH
     RRIHTGERPH VCPDCGKSFS KSSDLRAHHR THTGEKPYGC HDCGKCFSKS SALNKHGEIH
     AREKLLTQSA PK
//
